HYPERSENTIVITY DUE TO LINEZOLID IN ELDERLY PATIENTS: A CASE REPORT

Dr. Azher Sharif* and Dr. Zohra Fatima

ABSTRACT

Linezolid is recognized as the inaugural member within the oxazolidinone antibiotics category. Initially developed in 1978 for its efficacy in managing plant diseases, oxazolidinones demonstrated enhanced antibacterial properties compared to their precursor compounds six years later. These improved characteristics marked the oxazolidinone compounds as the primary lead entities in the oxazolidinone family. Linezolid was introduced in 1996 and has since been acknowledged as a leading compound. The US Food and Drug Administration granted approval for Linezolid in 2000. Over the past four decades, oxazolidinones have been recognized as a genuinely novel class of antibiotics now employed in clinical settings.[1]

Keywords: .